تحميل...
Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?
BACKGROUND: Investigate the impact of the reduction of the number of target lesions on immune-related response assessment in advanced melanoma patients treated with ipilimumab. METHOD: Ninety patients (53 males, 37 females; age range: 25–87) with advanced melanoma treated with ipilimumab in two clin...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BioMed Central
2014
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4077549/ https://ncbi.nlm.nih.gov/pubmed/24991412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-2-17 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|